The FDAs Pharmaceutical Compounding Advisory Committee (PCAC) voted to add six of seven peptides to the 503A Bulk Drug Substance List, despite FDA scientists recommending against all of them because of limited evidence of their safety and effectiveness
Weight-bearing mechanical stress is a primary stimulus for bone maintenance and remodeling
However, expression of the gene encoding LCAD (ACADL) is very low and restricted in humans and, therefore, LCAD does not contribute, to any significant extent, to long-chain fatty acid oxidation
Time needed for improvement ranges from a few days to several weeks, depending on the individual
When the body undergoes rapid changes in weight or nutrition, bone density can be affected
These side effects will stop when the medication is discontinued